Editorial ArticleSmall molecule therapeutics continue to have a big impact on the pharmaceutical industry
Editorial ArticleThe potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection
Editorial ArticleMicroglia precision reprogrammed from human iPSCs expand the toolkit for neurodegenerative disease modeling
Editorial ArticleEnhance antibody and lateral flow assay development through partnership with experts
Industry NewsBeckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System